Heron Therapeutics Inc (NASDAQ:HRTX)
| 1.34 Delayed Data As of Dec 01 |  +0.11 / +8.94%Today’s Change | 0.50 Today|||52-Week Range 3.41 | -46.40% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Velan Capital Investment Management Lp Director |  Buy | 7/21/2023 | 2,486,744 | $1.37 | $3.4M | -4.35% |
Collard Craig A Chief Executive Officer | Buy | 11/16/2023 | 150,000 | $0.92 | $138.0K | +43.98% |
Duarte Ira Chief Financial Officer & Executive Vice President | Buy | 11/16/2023 | 85,000 | $0.89 | $75.7K | +43.98% |
Forbes William P Chief Development Officer & Executive VP | Buy | 11/16/2023 | 50,000 | $0.94 | $47.0K | +43.98% |
Forbes William P Chief Development Officer & Executive VP | Buy | 11/17/2023 | 25,000 | $1.09 | $27.3K | +21.10% |
Peraza Lisa Chief Accounting Officer & Vice President |  Sale | 7/25/2023 | 14,743 | $1.51 | $22.3K | -12.58% |
Quart Barry D Chief Executive Officer | Sale | 1/13/2023 | 5,219 | $3.17 | $16.5K | -58.36% |
Manhard Kimberly J | Sale | 1/13/2023 | 2,012 | $3.17 | $6.4K | -58.36% |
Poyhonen John W President & Chief Compliance Officer | Sale | 1/13/2023 | 2,012 | $3.17 | $6.4K | -58.36% |
Szekeres David L Chief Operating Officer & EVP | Sale | 1/13/2023 | 2,012 | $3.17 | $6.4K | -58.36% |
Page of 6